Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Werewolf Therapeutics Q1 EPS $(0.39) Misses $(0.35) Estimate, Sales $742.00 Miss $1.82M Estimate

Author: Benzinga Newsdesk | May 03, 2024 07:19am

Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.35) by 11.43 percent. This is a 14.71 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $742.00 which missed the analyst consensus estimate of $1.82 million by 99.96 percent. This is a 99.98 percent decrease over sales of $4.46 million the same period last year.

Posted In: HOWL